![Dror Mevorach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dror Mevorach
Corporate Officer/Principal chez
Hadassah University Hospital
Profil
Dror Mevorach was the founder of Enlivex Therapeutics Ltd. (2005) as Chief Scientific & Medical Officer.
Dr. Mevorach was the founder of Enlivex Therapeutics Ltd. (2009) as Chief Scientific & Medical Officer.
Dr. Mevorach is currently the Chairman-Medicine at Hadassah University Hospital.
Dr. Mevorach holds a doctorate from Technion-Israel Institute of Technology.
Postes actifs de Dror Mevorach
| Sociétés | Poste | Début |
|---|---|---|
Hadassah University Hospital
 Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Corporate Officer/Principal | - |
Anciens postes connus de Dror Mevorach
| Sociétés | Poste | Fin |
|---|---|---|
| ENLIVEX | Fondateur | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Fondateur | - |
Formation de Dror Mevorach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hadassah University Hospital
Hadassah University Hospital Hospital/Nursing ManagementHealth Services Operates hospitals and universities | Health Services |
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
Enlivex Therapeutics Ltd.
 Enlivex Therapeutics Ltd. BiotechnologyHealth Technology Develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions | Health Technology |
